US debt crisis: Mark Cuban warns America’s $38 trillion debt is tied to broken healthcare pricing - here’s his solution

Mark Cuban warns about US debt crisis: Mark Cuban is weighing in on America’s ballooning national debt, arguing that fixing deep problems in the healthcare system, particularly insurance and drug pricing, could help ease some of the pressure driving federal deficits.

Mark Cuban links healthcare reform to America’s $38 trillion national debt

On Christmas Eve, the billionaire investor and entrepreneur took to social media X to voice his frustration with the insurance industry, saying insurers and providers “play on the fear and information asymmetry that exists in healthcare," as quoted by a report. Cuban called for these players to be broken up in order to “make the markets efficient again,” pointing to excessive billing and denied care as symptoms of a system that lacks transparency, as per a Fortune report.

US debt surge adds urgency to healthcare cost debate

Cuban’s comments come as the US national debt surged past $38 trillion in October, growing by roughly $1 trillion in just over two months in 2025, about twice the pace seen on average since 2000, as per Peter G. Peterson Foundation, reported Fortune. Annual interest payments on the debt are already near $1 trillion and could reach as much as $14 trillion over the next decade, a trajectory the foundation warned is “no way for a great nation like America to run its finances," as quoted by Fortune.


Also read: GME stock surges as CEO Ryan Cohen’s $35 billion pay plan targets GameStop to hit $100 billion market cap

Cuban criticizes insurers over opaque pricing and denied care

While Cuban has suggested fines, such as $100 penalties for insurers that over-bill or improperly deny care, his broader argument centers on removing opaque middlemen and enforcing transparent pricing. He points to the online pharmacy company he founded in January 2022, Cost Plus Drugs, as a working example of how that approach can lower costs.

How Cost Plus Drugs uses transparent pricing to cut medication costs

Cost Plus Drugs sells medications at their manufacturing cost plus a flat 15% markup, a small pharmacy fee, and a clearly listed shipping charge, as per the Fortune report. The company bypasses traditional pharmacy benefit managers, or PBMs, negotiates directly with manufacturers, and publicly posts its pricing formulas so customers can see how prices are calculated.

Also read: Intel stock rallies 9% - what is driving INTC shares up today? Key reasons

Why Cuban wants to eliminate healthcare middlemen

As per multiple reports, this model can reduce the cost of some generic drugs from thousands of dollars a month to double-digit prices, particularly for uninsured patients or those with high deductibles. Cuban argues that applying similar transparency and direct-to-consumer principles across healthcare, such as allowing cash prices to count toward insurance deductibles, could remove layers of waste that burden households and, by extension, public finances.

PBMs face growing scrutiny over drug price markups

PBMs, which negotiate drug prices on behalf of insurers, have increasingly come under scrutiny. Former Federal Trade Commission Chair Lina Khan publicly criticized them as “prescription drug middlemen,” and led a multi-year investigation into the sector, as per the Fortune report. An interim FTC report released in January 2025 claimed that PBMs marked up drugs by $7.3 billion above their acquisition costs. While significant, that figure is small compared with the scale of the national debt.

Cuban says healthcare savings could reach tens of billions

Cuban acknowledged that national debt is so gigantic, agreeing that even billions in savings would only be a starting point. He said, however, that abuse in the system is “far more than $7.3 billion,” and pointed out that moving brand-name drugs to net pricing could save patients tens of billions of dollars annually during deductible phases, as per the Fortune report.

To illustrate his point, Cuban compared current pharmacy pricing to a hypothetical snack distributor paying full retail prices and relying on uncertain rebates, saying, "Can you imagine if a Pringles distributor paid full retail to Pringles and then sold to grocery stores for full retail, and then the grocery stores had to wait for a rebate that may or may not cover their cost to buy the Pringles? That’s how pharmacy works. It makes no sense,” as quoted by Fortune.

Healthcare costs emerge as a key issue ahead of 2026 midterms

The debate is unfolding as healthcare costs become a growing political issue ahead of the 2026 midterm elections. As Affordable Care Act insurance subsidies expired in December, many Americans are facing higher premiums or opting to go uninsured, as per The New York Times. Polling consistently shows the economy as voters’ top concern, with healthcare costs frequently ranking near the top. An October 2025 poll by Families USA found that 43% of voters said lowering healthcare costs should be Congress’s highest priority.

Economists and health-policy experts caution that while prescription drug savings and billing reform could help, they would only address part of a debt problem driven by structural deficits, rising interest costs, and political gridlock. They say Cuban’s pharmacy model highlights how prices can be lowered and middlemen exposed, but it is unlikely to be a cure-all for a $38 trillion debt challenge, as per the Fortune report.

FAQs

What is Mark Cuban’s main argument about national debt?
He believes fixing inefficiencies in healthcare pricing could help reduce financial pressure contributing to federal deficits.

Why is Cuban critical of insurance companies?
He says insurers and providers take advantage of fear and information gaps in healthcare.